We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sitka Health | LSE:STH | London | Ordinary Share | GB0030199391 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 142.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:9495X Sitka Health Fund VCT PLC 07 June 2007 SITKA HEALTH FUND VCT plc INTERIM MANAGEMENT STATEMENT FOR THE 3 MONTHS TO 30 APRIL 2007 To the members of Sitka VCT plc This interim management statement has been prepared solely to provide additional information to the shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by any other party or for any other purpose. This interim management statement considers the future of the fund and, as such, forward-looking assertions have been made by the Directors in good faith based on the information available to them up to the time of their approval of this report. This statement should therefore be treated with due caution due to the inherent uncertainties of the effect of both economic and business risk factors in considering forward-looking information. This interim management statement relates to the period from 1 February 2007 to 30 April 2007 and contains information that covers this period and up to the date of publication of this interim management statement. Our operations Sitka Health Fund VCT plc provides investors with a return by maximising the stream of dividend distributions from the capital gains and income generated from a diversified portfolio of investments in the health sector. Our investment policy * To create a balanced portfolio of growth companies in the health sector * To invest in companies which have proven management and technology or business propositions which are protected by patents or know-how and where there are barriers to entry for competitors * Investments may include unquoted early-stage companies, those requiring development capital and companies raising money on AIM Progress during the period During the period the Net Asset Value increased from 89.5p per share at 31 January 2007 to 90.56p per share at 30 April 2007. This increase is mainly due to upward market movements. At 30 April 2007 the portfolio consisted of a total of 16 companies diversified across the health sector and at different stages of development. Of these companies 8 are quoted and 8 are unquoted. A total of #663,802 was invested during the period. In the recent Annual Report it was noted that the offer of Ordinary shares closing on 5 April 2007 had raised #5.8m. It is hoped to invest approximately 40% of this in the next year, both in new companies and in follow-on investments in existing companies. VCT qualifying status The Fund continues to receive full Inland Revenue approval and had 77.61% of the Fund's ordinary share capital which has to be invested in qualifying companies as at 30 April 2007, in addition to meeting the other tests necessary for maintaining VCT qualifying status. Annual General Meeting The annual general meeting of the Company will be held on Thursday 7th June 2007 at 2.30pm at the offices of Noble Group, 120 Old Broad Street, London, EC2N 1AR, where the Chairman of the Company will present her report for the year and Fund Managers, Gerard Tardy and Louis Nisbet, will present an overview of the prospects of the health sector in the UK. 120 Old Broad Street By order of the Board London EC2N 1AR Gill Nott (OBE) Director 6th June 2007 This information is provided by RNS The company news service from the London Stock Exchange END IMSMGGGVGNLGNZM
1 Year Sitka Health Fund Vct Chart |
1 Month Sitka Health Fund Vct Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions